INT171634

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.05
First Reported 2002
Last Reported 2002
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 6
Disease Relevance 0.96
Pain Relevance 0.29

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (TAB3) plasma membrane (TAB3) intracellular (TAB3)
Anatomy Link Frequency
leukocyte 2
platelet 2
TAB3 (Homo sapiens)
Pain Link Frequency Relevance Heat
ischemia 84 79.44 Quite High
anesthesia 6 64.88 Quite High
antagonist 6 57.72 Quite High
aspirin 6 9.92 Low Low
Kinase C 18 5.00 Very Low Very Low Very Low
cytokine 6 5.00 Very Low Very Low Very Low
Inflammation 6 5.00 Very Low Very Low Very Low
Inflammatory marker 6 5.00 Very Low Very Low Very Low
imagery 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Adhesions 126 95.76 Very High Very High Very High
Cv Unclassified Under Development 84 79.44 Quite High
Injury 90 52.84 Quite High
Increased Venous Pressure Under Development 30 41.28 Quite Low
Thrombosis 18 29.84 Quite Low
Leukopenia 6 22.84 Low Low
Pressure And Volume Under Development 6 5.56 Low Low
Stress 30 5.00 Very Low Very Low Very Low
Myocardial Infarction 30 5.00 Very Low Very Low Very Low
INFLAMMATION 12 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In tAB and tEF groups there was a significant increase in arteriolar diameter compared with I/R whereas in the groups treated with t-Pa combined with gpIIa/IIIb inhibitors, diameters maintained or increased its baseline value at the end of the observation period (tAB: +12% and tEF: + 15% vs. the AB and EF groups, respectively p < 0.05).
Gene_expression (groups) of tAB
1) Confidence 0.05 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.10 Pain Relevance 0.03
In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05)

Changes in platelet and leukocyte adhesion on microvessels

Gene_expression (groups) of tAB in leukocyte associated with adhesions
2) Confidence 0.05 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.17 Pain Relevance 0.04
In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05)

Changes in platelet and leukocyte adhesion on microvessels

Gene_expression (groups) of tAB in leukocyte associated with adhesions
3) Confidence 0.05 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.17 Pain Relevance 0.04
g/100 g infused intravenously); the fifth group (tAB, n = 6) was treated with t-PA plus abciximab (50 plus 0.6 ?
Gene_expression (group) of tAB
4) Confidence 0.04 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.16 Pain Relevance 0.10
In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05)

Changes in platelet and leukocyte adhesion on microvessels

Gene_expression (groups) of tAB in platelet associated with adhesions
5) Confidence 0.02 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.17 Pain Relevance 0.04
In AB and EF groups a slight increase in permeability was observed from 20–30 min after reperfusion when compared with tEF and tAB groups (tAB -25% and tEF: -57% vs. the ABI and EF groups, respectively, p < 0.05)

Changes in platelet and leukocyte adhesion on microvessels

Gene_expression (groups) of tAB in platelet associated with adhesions
6) Confidence 0.02 Published 2002 Journal BMC Cardiovasc Disord Section Body Doc Link PMC117121 Disease Relevance 0.17 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox